Roche's decision to invest heavily in the US – along with Novartis' announcement, has come hard on the heels of European ...

A Houston-based compounding pharmacy that was recently roped into Eli Lilly’s fight against knockoff GLP-1s has landed in the FDA’s crosshairs for the second time in less than a year. | The FDA has ...

It’s about what is possible when innovation meets intention,” Mary Ogangwu, chief Operating officer of Codix Bio, said at a press briefing in Lagos. Access to timely and accurate diagnostics remains a ...

In addition, the company is planning to build a new plant in Indiana for continuous glucose monitoring devices and a state-of-the-art gene therapy manufacturing facility in Pennsylvania ...

Bayer AG (Leverkusen, Germany) announced the grand opening of its new 70,000 square foot expansion at its Myerstown, ...

The French pharma group said the S$800 million ... while AbbVie broke ground on a $223 million expansion of its biologics manufacturing facility that is due to come online in 2026 and Novartis ...

Once the new and expanded manufacturing capacities are operational, Roche aims to export more medicines from the US than it ...

But pharma companies could potentially avoid ... Planned new sites include a gene therapy manufacturing facility in Pennsylvania, a glucose monitor manufacturing site in Indiana, and a new R ...

Nigeria is set to begin local production of rapid diagnostic test kits for HIV and malaria in May 2025. This move is expected ...

A new manufacturing facility in Indiana designed to make continuous ... Roche is the latest pharma giant to announce plans for expanding large-scale manufacturing in the United States.